Brookline Capital Markets analyst Kemp Dolliver lowered the price target on Dare Bioscience (NASDAQ: DARE) to $11.00 (from $14.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Form S-8 Dare Bioscience, Inc. August 14, 2025 5:00 PM Dare Bioscience (DARE) Misses Q2 EPS by 45cAugust 14, 2025 4:48 PM Form 10-Q Dare Bioscience, Inc. For: Jun 30August 14, 2025 4:08 PM Form 8-K Dare Bioscience, Inc. For: Aug 14August 14, 2025 4:06 PM Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 14, 2025 4:01 PM